Concepedia

Marga Nijenhuis

MN

Statistics

Publications

21

Citations

1.8K

H-Index

19

Active since

1994

Affiliations

University Medical Center Utrecht(Current)

Royal Dutch Pharmacists Association

Radboud University Nijmegen

Radboud University Medical Center

University of Groningen

Marga Nijenhuis is an author at University Medical Center Utrecht specializing in life sciences, immunology, and major histocompatibility complex.

ORCID

Publications per year

1994–2024

21

Publications

21

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

, , +13

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines

Carin A.T.C. Lunenburg, Cathelijne H. van der Wouden, Marga Nijenhuis et al. · European Journal of Human Genetics · 2019 · 233 citations · Full text

, , +17

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs

J. Brouwer, Marga Nijenhuis, Bianca Soree et al. · European Journal of Human Genetics · 2021 · 129 citations · Full text

, , +14

Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site

Marga Nijenhuis, G J Hämmerling · The Journal of Immunology · 1996 · 113 citations · Full text

, , +16

The endoplasmic reticulum‐resident stress protein gp96 binds peptides translocated by TAP

Eckhard Lammert, Danièle Arnold, Marga Nijenhuis et al. · European Journal of Immunology · 1997 · 113 citations

, , +17

1–5 of 21